Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registry.
Pfohl M, Pscherer S, Fritsche A, Anderten H, Borck A, Pegelow K, Bramlage P, Seufert J. Pfohl M, et al. Among authors: seufert j. Diabetes Obes Metab. 2019 Sep;21(9):2169-2173. doi: 10.1111/dom.13768. Epub 2019 May 29. Diabetes Obes Metab. 2019. PMID: 31069944
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J; Liraglutide-Detemir Study Group. DeVries JH, et al. Among authors: seufert j. Diabetes Care. 2012 Jul;35(7):1446-54. doi: 10.2337/dc11-1928. Epub 2012 May 14. Diabetes Care. 2012. PMID: 22584132 Free PMC article. Clinical Trial.
Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M, Siegmund T, Pscherer S, Pegelow K, Seufert J. Pfohl M, et al. Among authors: seufert j. Vasc Health Risk Manag. 2015 Nov 6;11:569-78. doi: 10.2147/VHRM.S82720. eCollection 2015. Vasc Health Risk Manag. 2015. PMID: 26604774 Free PMC article.
Trend of antihyperglycaemic therapy and glycaemic control in 184,864 adults with type 1 or 2 diabetes between 2002 and 2014: Analysis of real-life data from the DPV registry from Germany and Austria.
Bohn B, Kerner W, Seufert J, Kempe HP, Jehle PM, Best F, Füchtenbusch M, Knauerhase A, Hofer M, Rosenbauer J, Holl RW; DPV-initiative. Bohn B, et al. Among authors: seufert j. Diabetes Res Clin Pract. 2016 May;115:31-8. doi: 10.1016/j.diabres.2016.03.008. Epub 2016 Mar 12. Diabetes Res Clin Pract. 2016. PMID: 27242120
Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patients.
Siegmund T, Pfohl M, Forst T, Pscherer S, Bramlage P, Foersch J, Borck A, Seufert J. Siegmund T, et al. Among authors: seufert j. Diabetes Metab Syndr. 2017 Jan-Mar;11(1):51-57. doi: 10.1016/j.dsx.2016.08.006. Epub 2016 Aug 24. Diabetes Metab Syndr. 2017. PMID: 27578616
251 results